Lung Cancer Screening Knowledge in Four Internal Medicine Programs
dc.contributor.author | Urrutia Argueta, Samuel | |
dc.contributor.author | Basnet, Nishraj | |
dc.contributor.author | Abdul-Kafi, Owais | |
dc.contributor.author | Hanna, Nasser | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2023-11-02T17:32:29Z | |
dc.date.available | 2023-11-02T17:32:29Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Introduction: Lung cancer remains the leading cause of cancer-related death in the United States. Low density CT (LDCT) has been shown to reduce mortality in high-risk populations. Recognizing and mitigating gaps in knowledge in early medical training could result in increased utilization of screening CT in high risk-populations. Methods: An electronic survey was conducted among Internal Medicine (IM) residents at 4 academic programs in the Midwestern United States. A survey was distributed to evaluate knowledge about high-risk populations, mortality benefits, and a comparison in mortality benefits between LDCT and other screening modalities using number needed to screen (NNS). Results: There was a 46.6% (166/360) response rate. Residents correctly answered an average of 2.9/7 (43.1%) questions. PGY-1 (post-graduate year) and PGY-2 residents performed better than PGY-3 (P = .022). Only 1/3 rd of all respondents correctly identified the population needed to be screened. Over 80% of residents thought screening with LDCT had a cancer-specific mortality benefit but were evenly split (except Program 2 residents), on recognizing an all-cause mortality benefit with LDCT, (P = .016). Only 7.7% thought women benefited the most from LDCT. Self-assess and attained knowledge were similar among programs. Conclusions: LDCT is a noninvasive intervention with a substantial mortality reduction, especially in states with high rates of smoking, and is widely covered by insurers. With average knowledge score less than 50%, this study shows there is a substantial need to increase the knowledge of LCS in IM residency programs. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Urrutia Argueta S, Basnet N, Abdul-Kafi O, Hanna N. Lung Cancer Screening Knowledge in Four Internal Medicine Programs. Cancer Control. 2022;29:10732748221081383. doi:10.1177/10732748221081383 | |
dc.identifier.uri | https://hdl.handle.net/1805/36921 | |
dc.language.iso | en_US | |
dc.publisher | Sage | |
dc.relation.isversionof | 10.1177/10732748221081383 | |
dc.relation.journal | Cancer Control | |
dc.rights | Attribution-NonCommercial 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | PMC | |
dc.subject | Graduate medical education | |
dc.subject | Knowledge | |
dc.subject | Lung cancer | |
dc.subject | Lung cancer screening | |
dc.subject | Primary care | |
dc.title | Lung Cancer Screening Knowledge in Four Internal Medicine Programs | |
dc.type | Article |